October 12, 2018
Neopharma, an integrated pharmaceutical company, is pleased to report on a rewarding visit to the recent CPhI Worldwide 2018 exhibition which took place between October 9th and 11th in Madrid, Spain. Neopharma’s delegation together with their customers met business partners to from around the world at CPhI for to exchange information and discussions on the latest industry trends and development projects.
CPhI Worldwide is the largest and the most relevant event in the pharma industry calendar and, hosting more than 45,000 pharma professionals from over 150 countries, it has shown to be a great networking platform to meet with pharma industry representatives from all over the world, identify and develop important business opportunities. Over the past year, Neopharma exclusively focused on developing its API manufacturing facilities along with strengthening its finished product portfolio through various JV’s and acquisitions. CPHI Worlwide, presented the ideal platform for Neopharma to showcase its vertically integrated business.
Mr. Suresh Kumar Nadiraju, Chief Operating Officer, Neopharma commented “Over the past year, Neopharma has progressed from local company into a fully integrated global pharmaceutical company covering API and finished product manufacturing, catering to over 50 markets worldwide. CPHI provides perfect platform to showcase Neopharma’s manufacturing and marketing network. The needs of the pharmaceutical sector are continuously evolving; new challenges and opportunities arise every day and we are confident that Neopharma is well equipped, with the expertise and experience necessary, to seize them and assist our partners in finding the solution to their requirements.”